Invention Grant
- Patent Title: Targeted deletion of cellular DNA sequences
-
Application No.: US15610262Application Date: 2017-05-31
-
Publication No.: US10669557B2Publication Date: 2020-06-02
- Inventor: Dmitry Guschin , Fyodor Urnov
- Applicant: Sangamo Therapeutics, Inc.
- Applicant Address: US CA Richmond
- Assignee: Sangamo Therapeutics, Inc.
- Current Assignee: Sangamo Therapeutics, Inc.
- Current Assignee Address: US CA Richmond
- Agency: Pasternak Patent Law
- Main IPC: C12N15/85
- IPC: C12N15/85 ; C12N9/22 ; C12N15/10 ; C07K14/47

Abstract:
Disclosed herein are methods and compositions for targeted deletion of double-stranded DNA. The compositions include fusion proteins comprising a cleavage domain (or cleavage half-domain) and an engineered zinc finger domain, and polynucleotides encoding same. Methods for targeted deletion include introduction of such fusion proteins, or polynucleotides encoding same, into a cell such that two targeted cleavage events occur. Subsequent cellular repair mechanisms result in deletion of sequences between the two cleavage sites.
Public/Granted literature
- US20170298385A1 TARGETED DELETION OF CELLULAR DNA SEQUENCES Public/Granted day:2017-10-19
Information query
IPC分类: